The North America flutamide market is expanding steadily as the region continues to strengthen cancer care through improved diagnosis, advanced treatment protocols, and wider availability of hormone therapies. Rising prostate cancer cases, well-established healthcare systems, and ongoing investments in oncology research are key factors driving the regional market's growth. Market Growth...